Replies to post #166141 on Biotech Values

[ghmm]

Citi FoB panel:

For those of us not as well up on things its an interesting discussion (granted a somewhat biased view) on market/legislation/challenges etc.

[mcbio]

Listened to the Citi FoB panel with the AMGN executive (and two other guest speakers). Not surprisingly, AMGN’s public opinion is that the FDA will probably not approve interchangeable FoB’s during the next few years.

Do you disagree with that assertion?